natgillin/translations-raw huggingface dataset:
Pursuant to the provisions of Article 287 of the Treaty on the Functioning of the European Union (TFEU), the Court has audited: (a) theannualaccountsoftheCentre,whichcomprisethefinancialstatements(3)andthereportsontheimplementation of the budget (4) for the financial year ended 31 December 2015; and (b) the legality and regularity of the transactions underlying those accounts. 
Vastavalt Euroopa Liidu toimimise lepingu artikli 287 stetele auditeeris kontrollikoda: a) keskuse raamatupidamise aastaaruannet, mis koosneb finantsaruannetest(3) ja eelarve titmise aruannetest(4) 31. detsembril 2015. aastal lppenud eelarveaasta kohta; b) raamatupidamise aastaaruande aluseks olevate tehingute seaduslikkust ja korrektsust.
The management is responsible for the preparation and fair presentation of the annual accounts of the Centre and the legality and regularity of the underlying transactions (5): (1) OJ L 36, 12.2.1993, p. 1. 
Juhtkond vastutab keskuse raamatupidamise aastaaruande koostamise ja iglase esitamise eest ning aastaaruande aluseks olevate tehingute seaduslikkuse ja korrektsuse eest (5): (1) ET L 36, 12.2.1993, lk 1.
This Regulation and its amendments were repealed by Regulation (EC) No 1920/2006 of the European Parliament and of the Council (OJ L 376, 27.12.2006, p. 
Knealune mrus ja selle muudatused tunnistati kehtetuks Euroopa Parlamendi ja nukogu mrusega (E) nr 1920/2006 (ELT L 376, 27.12.2006, lk 1).
(2) More information on the CentreŐs competences and activities is available on its website: www.emcdda.europa.eu (3) These include the balance sheet and the statement of financial performance, the cash flow table, the statement of changes in net assets and a summary of the significant accounting policies and other explanatory notes. 
(2) Keskuse pdevust ja tegevust tutvustav tiendav teave on leitav keskuse veebisaidil www.emcdda.europa.eu. (3) Finantsaruanded sisaldavad bilanssi ja tulemiaruannet, rahavoogude aruannet, netovara muutuste aruannet, oluliste arvestusphimtete kokkuvtet ning muid selgitavaid lisasid.
42). 1.12.2016 Official Journal of the European Union C 449/129 EN (a) The managementŐs responsibilities in respect of the CentreŐs annual accounts include designing, implementing and maintaining an internal control system relevant to the preparation and fair presentation of financial statements that are free from material misstatement, whether due to fraud or error; selecting and applying appropriate accounting policies on the basis of the accounting rules adopted by the CommissionŐs accounting officer (6); making accounting estimates that are reasonable in the circumstances. 
1.12.2016 Euroopa Liidu Teataja C 449/129 ET a) juhtkonna kohustused seoses keskuse raamatupidamise aastaaruandega hlmavad finantsaruannete koostamiseks ja iglaseks esitamiseks vajaliku sisekontrollissteemi kavandamist, rakendamist ja kigushoidmist nii, et neis ei esineks pettusest vi vigadest tingitud olulisi vrkajastamisi; komisjoni peaarvepidaja poolt vastu vetud raamatupidami-seeskirjadel(6) phinevate asjakohaste arvestusphimtete valimist ja rakendamist ning arvestushinnangute koostamist, mis on asjaolusid arvestades mistlikud.
The Director approves the annual accounts of the Centre after its accounting officer has prepared them on the basis of all available information and established a note to accompany the accounts in which he declares, inter alia, that he has reasonable assurance that they present a true and fair view of the financial position of the Centre in all material respects. (b) The managementŐs responsibilities in respect of the legality and regularity of the underlying transactions and compliance with the principle of sound financial management consist of designing, implementing and maintaining an effective and efficient internal control system comprising adequate supervision and appropriate measures to prevent irregularities and fraud and, if necessary, legal proceedings to recover funds wrongly paid or used. 
Direktor kiidab keskuse raamatupidamise aastaaruande heaks prast seda, kui peaarvepidaja on selle kogu olemasoleva teabe phjal koostanud ning lisanud teatise, milles ta muu hulgas kinnitab, et omab piisavat kindlust selle kohta, et raamatupidamise aastaaruanne annab keskuse finantsolukorra kohta kikides olulistes aspektides ige ja iglase levaate; b) alustehingute seaduslikkuse ja korrektsuse tagamiseks ning usaldusvrse finantsjuhtimise phimtte jrgimiseks on juhtkond kohustatud kavandama, rakendama ja kigus hoidma mjusat ja thusat sisekontrollissteemi, mis hlmab piisavat jrelevalvet ja asjakohaseid meetmeid eeskirjade eiramise ja pettuse rahoidmiseks ning vajaduse korral iguslikke menetlusi valesti makstud vi kasutatud vahendite tagasinudmiseks.
These standards require the Court to plan and perform the audit to obtain reasonable assurance as to whether the annual accounts of the Centre are free from material misstatement and the transactions underlying them are legal and regular. 
Nende standardite kohaselt peab kontrollikoda auditi planeerima ja lbi viima viisil, mis annab talle piisava kindluse selle kohta, et keskuse raamatupidamise aastaaruanne ei sisalda olulisi vrkajastamisi ja selle aluseks olevad tehingud on seaduslikud ja korrektsed.
The audit involves performing procedures to obtain audit evidence about the amounts and disclosures in the accounts and the legality and regularity of the underlying transactions. The procedures selected depend on the auditorŐs judgement, which is based on an assessment of the risks of material misstatement of the accounts and material non-compliance by the underlying transactions with the requirements in the legal framework of the European Union, whether due to fraud or error. 
Auditi kigus viiakse lbi protseduure auditi tendusmaterjali kogumiseks aruandes esitatud summade ja andmete ning alustehingute seaduslikkuse ja korrektsuse kohta. Valitud protseduurid sltuvad audiitori otsustusest, mis phineb hinnangul riskidele, et aruanne vib sisaldada pettusest vi vigadest tulenevaid olulisi vrkajastamisi ning alustehingute mittevastavust Euroopa Liidu igusraamistikust tulenevatele nuetele.
In assessing these risks, the auditor considers any internal controls relevant to the preparation and fair presentation of the accounts, as well as the supervisory and control systems that are implemented to ensure the legality and regularity of underlying transactions, and designs audit procedures that are appropriate in the circumstances. The audit also entails evaluating the appropriateness of accounting policies, the reasonableness of accounting estimates and the overall presentation of the accounts. 
Asjakohaste auditiprotseduuride kavandamiseks vtab audiitor nimetatud riskide hindamisel arvesse raamatupidamise aastaaruande koostamise ja iglase esitamisega seonduvaid mistahes sisekontrollimehhanisme, samuti alustehingute seaduslikkuse ja korrektsuse tagamiseks rakendatud jrelevalve-ja kontrollissteeme. Audit hlmab ka arvestusphimtete asjakohasuse ja tehtud arvestushinnangute phjendatuse ning raamatupidamise aastaaruande ldise esitusviisi hindamist.
In preparing this report and Statement of Assurance, the Court considered the audit work of the independent external auditor performed on the CentreŐs accounts as stipulated in Article 208(4) of the EU Financial Regulation (8). 
Kesoleva aruande ja kinnitava avalduse koostamisel vttis kontrollikoda arvesse sltumatu vlisaudiitori audititd, mis hlmas keskuse raamatupidamise aastaaruande kontrollimist vastavalt ELi finantsmruse (8) artikli 208 likes 4 stestatud nuetele.
In the CourtŐs opinion, the transactions underlying the annual accounts for the year ended 31 December 2015 are legal and regular in all material respects. 
Kontrollikoja hinnangul on keskuse 2015. aasta 31. detsembril lppenud eelarveaasta raamatupidamise aastaaruande aluseks olevad tehingud kigis olulistes aspektides seaduslikud ja korrektsed.
(6) The accounting rules adopted by the CommissionŐs accounting officer are derived from the International Public Sector Accounting Standards (IPSAS) issued by the International Federation of Accountants or, where relevant, the International Accounting Standards (IAS)/International Financial Reporting Standards (IFRS) issued by the International Accounting Standards Board. 
(6) Komisjoni peaarvepidaja poolt vastu vetud raamatupidamiseeskirjad phinevad Rahvusvahelise Arvestusekspertide Fderatsiooni koostatud rahvusvahelistel avaliku sektori raamatupidamisstandarditel (IPSAS), vi vajaduse korral Rahvusvahelise Arvestusstandardite Nukogu koostatud rahvusvahelistel arvestusstandarditel (IAS)/rahvusvahelistel finantsaruandlusstandarditel (IFRS).
(7) Article 107 of Delegated Regulation (EU) No 1271/2013. 
(7) Delegeeritud mruse (EL) nr 1271/2013 artikkel 107.
(8) Regulation (EU, Euratom) No 966/2012 of the European Parliament and of the Council (OJ L 298, 26.10.2012, p. 
(8) Euroopa Parlamendi ja nukogu mrus (EL, Euratom) nr 966/2012 (ELT L 298, 26.10.2012, lk 1).
EN C 449/130 Official Journal of the European Union 1.12.2016 11. 
ET C 449/130 Euroopa Liidu Teataja 1.12.2016 11.
In 2012 the Centre signed a framework contract with a maximum amount for signing specific contracts of 250 000 euro, which was specified in the contract notice. 
2012. aastal allkirjastas keskus edasiste lepingute slmimiseks raamlepingu summas 250000 eurot, mis oli hanketeates mrgitud.
However, the Centre did not respect this ceiling. 
Keskus ei pidanud sellest piirmrast siiski kinni.
By the end of 2015 the total payments made under this contract amounted to 382 181 euro; i.e. exceeded it by 50 %. 
2015. aasta lpuks oli selle lepingu raames tehtud maksete summa kokku 382 181 eurot, st piirmr oli letatud 50 % vrra.
The payments made above the ceiling indicate that the CentreŐs procedure for monitoring framework contracts should be improved. 
Piirmra letavad maksed nitavad, et keskuse kasutatavat raamlepingute jrelevalvemenetlust tuleks parandada.
FOLLOW-UP OF PREVIOUS YEARŐS COMMENTS 13. An overview of the corrective actions taken in response to the CourtŐs comments from previous years is provided in the Annex. 
EELMISE AASTA KOMMENTAARIDE PÍHJAL VÍETUD MEETMED 13. levaade kontrollikoja eelmise aasta kommentaaride phjal vetud parandusmeetmetest on esitatud lisas.
1.12.2016 Official Journal of the European Union C 449/131 EN ANNEX Follow-up of previous yearsŐ comments Court's comment Carry-overs of committed appropriations were high for Title II (administrative expenditure) with 673534 euro, i.e. 26% (2013: 217061 euro, i.e. 9%). 
1.12.2016 Euroopa Liidu Teataja C 449/131 ET Kontrollikoja kommentaar Kulukohustustega seotud assigneeringute lekandmiste mr oli krge II jaotises (halduskulud) Đ 673 534 eurot ehk 26 % (2013. aastal 217 061 eurot ehk 9 %).
They mainly relate to an accelerated implementation of the multiannual ICT strategy, arising from resources initially planned for salary increases but not needed following a decision by the European Court of Justice. 
See tuleneb peamiselt mitmeaastase IKT-strateegia kiirendatud elluviimisest, mille phjuseks olid algselt palgatusuks planeeritud ressursid, mida prast Euroopa Kohtu otsust enam vaja ei linud.
Year 2014 Status of corrective action (Completed/Ongoing/Outstanding/N/A) N/A 
Aasta 2014 LISA Eelmise aasta kommentaaride phjal vetud meetmed Parandusmeetmete vtmise seis (lpetatud/pooleli/alustamata/ei kohaldata) Ei kohaldata
EN C 449/132 Official Journal of the European Union 1.12.2016 THE CENTREŐS REPLY 12. 
ET C 449/132 Euroopa Liidu Teataja 1.12.2016 KESKUSE VASTUS 12.
The framework contract concluded pursuant to this process neither mentioned this amount nor did it refer to any maximum threshold. 
Menetluse tulemusel slmitud raamlepingus ei mainitud seda summat ega piirmri.
The EMCDDA has terminated this contract and launched a new procurement procedure for the concerned services. 
EMCDDA on selle lepingu lpetanud ja alustanud asjaomaste teenuste jaoks uut hankemenetlust.
The Centre signed the contract in July 2016. 
Keskus slmis lepingu juulis 2016.
C 332/8 EN Official Journal of the European Union REPORT on the annual accounts of the European Medicines Agency for the financial year 2004 together with the AgencyŐs replies 28.12.2005 (2005/C 332/02) CONTENTS INTRODUCTION ........................................................... 
C 332/8 ET Euroopa Liidu Teataja ARUANNE Euroopa Ravimiameti 2004. eelarveaasta raamatupidamise aastaaruande kohta koos ameti vastustega 28.12.2005 (2005/C 332/02) SISUKORD SISSEJUHATUS .............................................................
THECOURTŐSOPINION ..................................................... 
3Đ6 9 THELEPANEKUD ..........................................................
7-9 9 Tables1to4 .......................................................................... 
7Đ9 9 Tabelid1Đ4 ...........................................................................
10 TheAgencyŐsreplies................................................................... 
10 Ametivastused ....................................................................... 14 Punkt Leheklg
28.12.2005 EN Official Journal of the European Union C 332/9 INTRODUCTION 1. 
28.12.2005 ET Euroopa Liidu Teataja C 332/9 SISSEJUHATUS 1.
The European Medicines Agency (hereinafter referred to as the Agency) was created by Council Regulation (EEC) No 2309/93 of 22 July 1993 which was replaced by Regulation (EC) No 726/2004 of the European Parliament and of the Council of 31 March 2004 (1). 
Euroopa Ravimiamet (edaspidi ŇametÓ) loodi nukogu 22. juuli 1993. aasta mrusega (EM) nr 2309/93, mis asendati Euroopa Parlamendi ja nukogu 31. mrtsi 2004. aasta mrusega (E) nr 726/2004.
The Agency operates through a network and coordinates the scientific resources made available by the national authorities in order to ensure the evaluation and supervision of medicinal products for human or veterinary use. 
(1) Amet toimib vrgustiku kaudu ja koordineerib siseriiklike ametiasutuste poolt kttesaadavaks tehtud teadusressursse, et tagada inim-vi veterinaarravimite hindamine ja jrelevalve.
Table 1 summarises the powers and activities of the Agency on the basis of the information supplied by it. 
Tabelis 1 on ameti poolt esitatud teabe phjal tehtud kokkuvte selle volituste ja tegevuse kohta.
For information, the annual accounts drawn up by the Agency for the financial year 2004 are summarised in Tables 2, 3 and 4. 
Informatsiooniks on ameti poolt koostatud 2004. eelarveaasta raamatupidamise aastaaruanne kokkuvtlikult esitatud tabelites 2, 3 ja 4.
The CourtŐs opinion is addressed to the European Parliament and the Council in accordance with Article 185(2) of Council Regulation (EC, Euratom) No 1605/2002 (2); it was drawn up following an examination of the AgencyŐs accounts, as required by Article 248 of the Treaty establishing the European Community. 
Kontrollikoja jreldusotsus on adresseeritud Euroopa Parlamendile ja nukogule koosklas nukogu mruse (E, Euratom) nr 1605/2002 artikli 185 likega 2; (2) see koostati prast ameti raamatupidamiskontode kontrollimist vastavalt Euroopa henduse asutamislepingu artiklile 248.
The AgencyŐs accounts for the financial year ended 31 December 2004 (3) were drawn up by its Executive Director, pursuant to Article 68 of Regulation (EC) No 726/2004, and sent to the Court, which is required to give its opinion on their reliability and on the legality and regularity of the underlying transactions. 
Vastavalt mruse (E) nr 726/2004 artiklile 68 koostas ameti tegevdirektor ameti raamatupidamisaruande 31. detsembril 2004. aastal lppenud eelarveaasta kohta (3) ja see saadeti kontrollikojale, mis peab andma arvamuse raamatupidamisaruannete usaldusvrsuse ja nende aluseks olevate tehingute seaduslikkuse ja korrektsuse kohta.
The AgencyŐs Management Board has set up an Audit Advisory Committee to advise the Executive Director on matters regarding quality assurance and risk-mitigating strategies. 
Ameti haldusnukogu on loonud kontrolli nuandekomitee, kelle lesandeks on ameti tegevdirektori nustamine kvaliteedi tagamise ja riskimaandamise strateegiate alal.
The existence of such a body and its operating procedures, including the recruitment procedure for its members, must be provided for, on account of its permanent nature, in the rules which govern the AgencyŐs internal organisation. 
Sellise organi psiva iseloomu tttu tuleb selle olemasolu ja tkord, sealhulgas liikmete vrbamise kord, stestada ameti sisemist korraldust reguleerivates eeskirjades.
The contracts concluded with the banks have been in force for over five years even though the detailed rules for the implementation of the AgencyŐs financial regulation lay down that there should be a new invitation to tender at least once every five years (4). 
Pankadega slmitud lepingud on kehtinud le viie aasta, kuigi ameti finantsmruse ksikasjalikud rakenduseeskirjad s-testavad vhemalt iga viie aasta jrel uue pakkumismenetluse korraldamise.
9. 
(4) 9.
The Court notes that the AgencyŐs new financial regulation, as finally adopted after receipt of the CommissionŐs opinion, takes account of the observations which the Court made in its previous report (5). Similarly, the system for managing the AgencyŐs fixed assets has been considerably improved (6). 
Kontrollikoda mrgib, et prast komisjoni arvamuse laekumist lplikult vastu vetud ameti uues finantsmruses vetakse arvesse kontrollikoja eelmises aruandes tehtud mrkusi. (5) Samuti on mrkimisvrselt parandatud ameti phivarade haldamise ssteemi.
This Report was adopted by the Court of Auditors in Luxembourg at its meeting of 5 October 2005. 
(6) Kontrollikoda vttis kesoleva aruande vastu 5. oktoobri 2005. aasta istungil LuxembourgŐis.
For the Court of Auditors Hubert WEBER President (1) OJ L 214, 24.8.1993, p. 1 and OJ L 136, 30.4.2004, p. 
Kontrollikoja nimel president Hubert WEBER (1) ET L 214, 24.8.1993, lk 1 ja ELT L 136, 30.4.2004, lk 1.
1. (3) These accounts were drawn up on 29 September 2005 and received by the Court on 29 September 2005. 
(3) Antud raamatupidamisaruanne koostati 29. septembril 2005. aastal ja kontrollikoda sai selle 29. septembril 2005. aastal.
(4) Article 53(3). 
(4) Artikli 53 lige 3.
(5) See paragraph 7 of the Report for the financial year 2003 (OJ C 324, 30.12.2004, p. 
(5) Vt 2003. eelarveaasta aruande punkt 7 (ELT C 324, 30.12.2004, lk 31).
(6) See paragraph 10 of the Report for the financial year 2003. 
(6) Vt 2003. eelarveaasta aruande punkt 10.
C 332/10 EN Official Journal of the European Union 28.12.2005 Areas of Community competence deriving from the Treaty Competences of the Agency Regulation (EC) No 726/2004 of the European Parliament and of the Council of 31 March 2004 Governance The Committee for Propri-Resources made available to the Agency (2003 figures) Products and services ties make available to the Community action, which Agency for the authorisa-Favourable opinions: 34 (39) Average evaluation time: 187 days (190 days) Opinions after authorisation: 926 (941) Pharmacovigilance: 64 186 reports (45 538 reports) Periodic reliability reports: 253 (276) Monitoring measures: 948 (1 025) Scientific opinions: 77 (65) Procedures for mutual recognition: 7 081 (4 080) Veterinary medicinal products New applications: 8 (10) Applications in respect of variants: 40 (64) Inspection: 93 (76) Objectives Tasks 1. 
C 332/10 ET Euroopa Liidu Teataja 28.12.2005 Asutamislepingust tulenevad henduse pdevus valdkonnad Ameti pdevus Euroopa Parlamendi ja nukogu 31. mrtsi 2004. aasta mrus (E) nr 726/2004 Juhtimine Ameti ksutusse antud ressursid Tooted ja teenused Kogu henduse poliitika ja meetmete mratlemisel ja rakendamisel tagatakse inimeste tervise krgetasemeline kaitse.
Member StatesŐ authori-To coordinate the scientific evaluation of medicinal products which are subject to Community marketing authorisation procedures; etary Medicinal Products, consisting of two members from each Member State, advises on any question relating to the evaluation of medicinal products for human use. 
Eesmrgid lesanded 1) Ravimpreparaatide komitee, mis koosneb kahest iga liikmesriigi esindajast, annab nu kikides inimravimite hindamist puudutavates ksimustes.
99,1 million euro lion euro) including the Community contribution (excluding subsidy for orphan medicines): 24,7 % (22,9 %) Applications for marketing authorisations: 51 (39) shall complement national tion and supervision of policies, shall be directed medicinal products for Ń towards improving public human and veterinary health, preventing human ill-use; ness and diseases and obviating sources of danger to Ń to provide the Member human health. (...) 
Lplik eelarve: Inimravimid henduse meetmed, mis tiendavad liikmesriikide poliitikat, on suunatud rahvatervise parandamisele, inimeste haiguste ennetamisele ja inimeste tervist ohustavate tegurite krvaldamisele. (...)
States and the institutions to coordinate the supervision of medicinal products which 2. have been authorised within the Community; (pharma-covigilance); The Committee for Veterinary Medicinal Products, consisting of two members from each Member State, advises on any question relating to the evaluation of veterinary medicinal products. 
Koordineerida henduses loa 2) saanud ravimite jrelevalvet (ravimiohutuse jrelevalve); Veterinaarravimite komitee, mis koosneb kahest iga liikmesriigi esindajast, annab nu kikides veterinaarravimite hindamist puudutavates ksimustes.
Staff numbers at 31 December 2004: (Article 152 of the Treaty) with scientific advice on medicinal products for to advise on the maximum limits for residues of veterinary medicinal products which may be accepted in 3. foodstuffs of animal origin; Posts occupied: 290 (256) Source: Information supplied by the Agency. of the European Union Ń 314 (287) posts provided for in the establishment plan human or veterinary use. The Management Board, consisting of two representatives of each Member State, two representatives of the Commission and two representatives appointed by the European Parliament. 
Personali suurus 31. detsembril 2004: Keskmine hindamisaeg: 187 peva (190 peva) (Asutamislepingu artikkel 152) Haldusnukogu koosneb kahest iga liikmesriigi esindajast, kahest komisjoni esindajast ja kahest Euroopa Parlamendi poolt nimetatud esindajast. Nukogu vtab vastu tprogrammi ja aasta ldaruande. (45 538 aruannet) Allikas: Ameti poolt esitatud teave.
The Board adopts the work programme and the annual report. Ń to coordinate verification of compliance with the principles of good manufacturing practice, good laboratory practice and good clinical practice; + 50 (48) other posts (auxiliary contracts, seconded national experts, local staff, employment agency staff) Ń to record the status of 4. marketing authorisations granted for medicinal products. 
Arvamused prast lubade andmist: 926 (941) Anda soovitusi veterinaarravimijkide lubatavate piirmrade kohta loomsetes toidu-ainetes; 3) 314 (287) tkohta ametikohtade loetelus Ravimiohutuse jrelevalve: 64 186 aruannet Ń Koordineerida vastavustendamist hea tootmistava, hea laboritava ja hea kliinilise tava phimtetega; + 50 (48) muud tkohta (lepingulised abittajad, lhetuses viibivad riiklikud eksperdid, kohalik personal, tjudu vahendava asutuse kaudu saadud ttajad) Perioodilised usaldusvrsuse aruanded: 253 (276) Ń Registreerida ravimimgilubade staatus.
Total staff: 340 (304) Assigned to the following duties: operational: 271 (242) administrative: 69 (62) Table 1 European Medicines Agency (London) 5. External audit: European Court of Auditors 6. 
Jrelevalvemeetmed: 948 (1 025) Teaduslikud arvamused: 77 (65) Tabel 1 Euroopa Ravimiamet (London) 5) Vlisaudit: kontrollikoda 6) Kinnituse annab parlament nukogu soovitusel.